Cite
Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications.
MLA
Bui, Indy, et al. “Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications.” Antioxidants & Redox Signaling, vol. 39, no. 13/15, Nov. 2023, pp. 853–89. EBSCOhost, https://doi.org/10.1089/ars.2023.0250.
APA
Bui, I., Baritaki, S., Libra, M., Zaravinos, A., & Bonavida, B. (2023). Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications. Antioxidants & Redox Signaling, 39(13/15), 853–889. https://doi.org/10.1089/ars.2023.0250
Chicago
Bui, Indy, Stavroula Baritaki, Massimo Libra, Apostolos Zaravinos, and Benjamin Bonavida. 2023. “Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications.” Antioxidants & Redox Signaling 39 (13/15): 853–89. doi:10.1089/ars.2023.0250.